Five Biologics Perform Strongly in Children With Psoriasis
Treatment with a biologic greatly boosts the likelihood that children with psoriasis will achieve a ...
Combo Provides ‘Broad Benefit’ Across NHL Subtypes
The combination of copanlisib plus rituximab led t...
After 24 Years, Doc Fired by Hospital. Local Uproar Followed.
For 24 years, Thomas Weiner, MD, worked as a medic...
GSK and Vir Seek Emergency Use of COVID-19 Therapy in United States
(Reuters) – GSK and Vir Biotechnology have f...
Denosumab Now Dominant Therapy for Cancer-Associated Osteoporosis
Amid a substantial expansion of therapies in sever...
Newly Approved Drugs Offer New Hope in NMOSD
While they’re extraordinarily expensive, a t...
Dupilumab an Option When Other Targeted Agents Fail in Aspirin-Exacerbated Respiratory Disease
NEW YORK (Reuters Health) – Dupilumab, a mon...
Anthracycline-Free Neoadjuvant Regimen Safe, Effective for TNBC
For patients with triple-negative breast cancer (T...
Pegilodecakin No Aid to FOLFOX in Metastatic Pancreatic Cancer
NEW YORK (Reuters Health) – Adding immunothe...
AstraZeneca, Sputnik Vaccines Face Hurdles With Annual COVID Shots
ZURICH (Reuters) – Vaccines from AstraZeneca...